Article
[Molecular pathology of brain tumors].
Anales de la Real Academia Nacional de Medicina - 1 Jan 2005
Sanz Esponera Julián
Abstract excerpt
Somatic genetic alterations can be used to differentiate primary from secundary glioblastomas. The molecular pathways involved in tumerogenesis have been described and we now have a better knowledge of tumor biology. Central Nervous System Tumors classification will probably include genetic changes in an early future with potential implications for therapy and patients prognostic.
Topics
- Astrocytoma
- Brain
- Brain Neoplasms
- Cell Cycle
- Diagnosis, Differential
- Glioblastoma
- Humans
- Mutation
- Prognosis
- World Health Organization